Biomerica Inc (BMRA) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2026, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Biomerica Inc   (NASDAQ: BMRA)
 

Biomerica Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Biomerica Inc inventory turnover ratio, the Biomerica Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 2.64 in the first quarter 2026, BMRA's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Biomerica Inc in Aug 31 2026 quarter, has decreased to 138 days, compare to 141 days, in the May 31 2026 quarter.

Within Healthcare sector 150 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1340, from total ranking in the fourth quarter 2026 at 1506.

BMRA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Biomerica Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BMRA Inventory Turnover Ratio (Aug 31 2026)
I. Quarter		 (May 31 2026)
IV. Quarter		 (Feb 28 2026)
III. Quarter		 (Nov 30 2025)
II. Quarter		 (Aug 31 2025)
I. Quarter
Y / Y Inventory Growth 10.93 % 14.56 % -0.6 % -14.81 % -24.15 %
Y / Y Cost of Sales Growth 21.55 % -5.12 % -6.27 % -3.34 % -37.02 %
Inventory Turnover Ratio (TTM) 2.64 2.58 2.7 2.74 2.65
BMRA's Total Ranking # 1340 # 1506 # 1459 # 1393 # 1489
Average inventory processing period 138 142 135 133 138
Seq. Inventory Growth -4.28 % 3.77 % 7.94 % 3.46 % -1.14 %
Seq. Cost of Sales Growth 22.96 % -8.34 % -11.04 % 21.23 % -4.02 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 6
Healthcare Sector # 151
Overall Market # 1340

Inventory Turnover Ratio Statistics
High Average Low
6.03 2.37 1.64
(Aug 31 2022)   (Nov 30 2020)



BMRA Company Profile >> Back to BMRA Efficiency Comparisons >> Compare BMRA Inventory Turnover Ratio to its Competitors

Financial Statements
Biomerica Inc 's Inventories $ 2 Millions Visit BMRA's Balance sheet
Biomerica Inc 's Cost of Revenues TTM $ 4 Millions Visit BMRA's Income Statement
What are BMRA's Sales? Visit BMRA's Sales by Segment

Other Inventory Turnover Ratios
Biomerica Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BMRA's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BMRA's Competitors
Inventory Turnover Ratio for BMRA's Suppliers
Inventory Turnover Ratio for BMRA's Customers

You may also want to know
BMRA's Sales Growth Rates BMRA's Pe Price to earnings ratio BMRA's Receivables Turnover Ratio BMRA's Stock Quote
BMRA's Net Income Growth Rates BMRA's Ps Price to Sales ratio BMRA's Sales per Employee BMRA's Asset Turnover Ratio
BMRA's Net Margin BMRA's Pb Price to Book ratio BMRA's Financial Strength Ratios BMRA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Aug 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Aug 31 2026 Inventories at quarter ending Aug 31 2026
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Cardiff Lexington Corporation  6.98 $ 3.768  Millions$ 1  Millions
Carlsmed Inc   6.91 $ 15.844  Millions$ 2  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Coherus Oncology inc   3.50 $ 16.193  Millions$ 5  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions

Date modified: 2026-10-16T04:51:24+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.